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CD8+ cytotoxic T lymphocytes are key effectors of adaptive immunity for the control of virus infections. Epitope-specific responses are
hierarchical and the rules for dominance are not well defined. Here we show that the H2-Kd-restricted RSV M282–90 (K
dM282–90) epitope
dominates the H2-Db-restricted RSV M187–195 (D
bM187–195) epitope and influences epitope-specific effector function in the acute and memory
phases of the immune response to primary RSV infection in H-2b/d hybrid mice. The hybrid mouse model provides a system to define rules of
epitope hierarchy and better understand how antigen presentation and epitope competition affect the phenotype of effector and memory T cells.
Published by Elsevier Inc.Keywords: RSV; CD8+ CTL; Epitope; Mice; ImmunodominanceIntroduction
Respiratory syncytial virus (RSV) is a pneumovirus that
carries a considerable public health cost. Development of a
vaccine for RSV is therefore considered a top priority in
developed countries (Collins et al., 2001). In the majority of
virus infections, including RSV, the CD8+ T cell is responsible
for the elimination of virus-infected cells (Cannon et al., 1988;
Doherty and Christensen, 2000; Graham et al., 1991; Harty et
al., 2000; Wong and Pamer, 2003). CD8+ T cells recognize
processed virus antigens in the context of class I MHC
expressed by APCs, resulting in a highly specific response
(Zinkernagel and Doherty, 1974). Immunogenic peptide
epitopes vary in the magnitude of the response that they induce,
resulting in a hierarchy of epitope dominance (Kedl et al.,
2003). Factors that determine whether a specific epitope is
immunodominant or subdominant include antigen abundance,
the efficiency of antigen processing, binding affinity to the class
I MHC groove, competition for class I MHC molecules, recog-⁎ Corresponding author. Fax: +1 301 480 2771.
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TCR, and signaling pathways triggered at the time of TCR
interaction (Kedl et al., 2003; Yewdell and Bennink, 1999).
Moreover, subdominant epitopes can ascend to dominance if
the immunodominant epitope is eliminated (Chen et al., 2000;
Johnstone et al., 2004), during secondary responses (Belz et al.,
2000, 2001; Selin et al., 1999), or depending on the density of
antigen expression (Moskophidis et al., 1993; Probst et al.,
2003; Zajac et al., 1998).
We have recently identified an H2-Db-restricted CD8+ T cell
epitope from the RSV M protein (DbM187–195, NAITNAKII) in
C57Bl/6 mice (Rutigliano et al., 2005). This allowed us to begin
investigating epitope hierarchy in H-2d/b hybrid CB6F1/J mice,
which are the F1 generation of a BALB/c×C57Bl/6 mating. In
this report, we compare the CD8+ T cell responses to KdM282–90
(SYIGSINNI) and DbM187–195 in RSV-infected CB6F1/J mice to
the responses in the parent strains.
Results
The illness pattern and viral replication in CB6F1/J mice
mimic the parental strains
We first examined illness as defined by weight loss in RSV-
infected CB6F1/J mice. RSV-induced illness in CB6F1/J mice
Fig. 2. Quantitation of CD8+ T cells in the lungs of RSV-infected mice.
Percentages of CD3+CD8+ T cells were determined by flow cytometry of lung
lymphocytes from mice sacrificed at 4, 6, 8, 10, and 14 days post RSV-infection.
The data represent 3 independent experiments.
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(Fig. 1A), but the hybrid mice showed no physical signs of
illness, such as ruffled fur, inactivity, rapid breathing, or gaunt
posture (data not shown), commonly seen in BALB/c mice.
Viral titers in the lungs of C57Bl/6 mice were 1.5 to 2 logs lower
than those of CB6F1/J and BALB/c mice on day 4 post-
infection, which is the peak of virus replication in the lungs of
mice. All three strains of mice had similar kinetics of viral
clearance, with a reduction in titer on day 6, and little to no
detectable virus by day 8 post-infection (Fig. 1B).
Enumeration of epitope-specific CD8+ T cells in CB6F1/J mice
reveals a hierarchy of epitope specificity
We have previously determined that the CD8+ T cell
response to the novel DbM187–195 epitope in C57Bl/6 mice is
similar to the response induced by the KdM282–90 epitope in
BALB/c mice (Rutigliano et al., 2005). To characterize the
CD8+ T cell response in the hybrid mouse, we first measured
the total T cell response in the lungs of both parent strains
and the hybrid mice after RSV infection. The percentage andFig. 1. (A) Illness in RSV-infected mice. RSV-A2 infected parent and hybrid
mice were weighed daily to monitor virus-induced illness. Averages and
standard deviations were calculated from results with 5 mice per group. The data
represent 3 independent experiments. (B) Clearance of virus-infected cells from
the lungs of RSV-infected mice. Lung viral titers were determined by a standard
plaque assay as described (11) in all three strains of RSV-A2-infected mice. The
limit of detection is 1.8 log10 pfu/g of lung tissue. Geometric means and standard
deviations were calculated from results with 5 mice per group. The data
represent 3 independent experiments. The day 4 virus titer in C57Bl/6 mice is
significantly lower than the titer in BALB/c or CB6F1/J mice (P<0.05,
Student's t-test).absolute numbers of CD8+ T cells in the lung rose through
day 8 and waned by day 14, nearly returning to baseline
levels (Fig. 2). CD8+ T cell numbers were similar in all three
strains of mice at each time point. Next we defined the time
course of the epitope-specific CD8+ T cell response in each
strain with tetramers that recognize CD8+ T cells specific for
each epitope (KdM282–90 tetramer and D
bM187–195 tetramer)
as described (Rutigliano et al., 2005). The percentage of
KdM282–90 tetramer positive CD8+ T cells approached 50%
in BALB/c mice at day 10 (Fig. 3A), and DbM187–195
tetramer positive CD8+ T cells approached 40% in C57Bl/6
mice (Fig. 3B). In CB6F1/J mice, the number of CD8+ T
cells specific for KdM282–90 was more than 3-fold higher than
DbM187–195-specific CD8+ T cells in 4 independent experi-
ments (Figs. 3C and D), demonstrating a clear epitope
hierarchy.
The DbM187–195 epitope elicits a lower magnitude of T cell
responses that more consistently produce cytokines compared
to responses elicited by the KdM282–90 epitope in both primary
and memory responses
Functional differences in the epitope-specific responses
between parent and hybrid strains were assessed by intracellular
cytokine staining (ICS) for antiviral cytokine production as
described (Rutigliano et al., 2005), in parallel with tetramer
staining by stimulating additional lung lymphocyte samples
with either M282–90 or M187–195 peptide in combination with
anti-CD49d and anti-CD28 antibodies for co-stimulation. We
found that between 40 and 80% of the epitope-specific cells (as
quantitated by surface tetramer staining) in BALB/c and C57Bl/
6 parent strains were able to respond to peptide by the
production of IFN-γ, TNF-α, or both cytokines simultaneously
(Figs. 3A and B). As previously indicated by tetramer staining,
the magnitude of the M282–90 response was higher than the
M187–195 response in hybrid mice (Figs. 3C and D). Interest-
ingly, despite lower frequencies of DbM187–195-specific cells in
CB6F1/J mice, and the subdominant status of this epitope, a
higher proportion of the DbM187–195 epitope-specific cells were
Fig. 3. Epitope-specific CD8+ T cell responses in the lungs of RSV-infected parent strains and hybrid mice. KdM282–90- and D
bM187–195-specific CD8+ T cells were
quantitated by tetramer staining lung lymphocytes at days 4, 6, 8, and 10 post-infection. KdM282–90 tetramer staining was done for BALB/c and CB6F1/J mice, and
DbM187–195-tetramer staining was done for C57Bl/6 and CB6F1/J mice. Antiviral cytokine production by CD3+CD8+ T cells was determined separately by ICS after
in vitro peptide stimulation with M282–90 or M187–195 peptides. Panels A (K
dM282–90 responses) and B (D
bM187–195 responses) indicate responses for the BALB/c and
C57Bl/6 parent strains, respectively. Panels C (KdM282–90) and D (D
bM187–195) represent quantitated epitope-specific responses in the CB6F1/J hybrid. The data are
representative of 3 independent experiments, with background (DbNP366–374 tetramer stained, or flu peptides, ASNENMETM and/or TYQRTRALV, -stimulated)
subtracted.
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stimulation (Fig. 3D).
The predominant cytokine response to stimulation with
either the M82–90 or the M187–195 peptides was the production of
IFN-γ. Increased production of TNF-α was seen on day 10
post-infection. However, most of these cells produced IFN-γ.
Very few antigen-specific T cells produced only TNF-α,
suggesting that cells producing TNF-α are a subset of cells
producing IFN-γ during RSV infection. This phenomenon has
also been demonstrated in influenza infection (Barber et al.,
2005; La Gruta et al., 2004).
We next asked if KdM282–90-specific CD8+ T cells remained
dominant in the memory phase after infection of CB6F1/J. We
sacrificed RSV-infected CB6F1/J mice 42 days post-infection
and analyzed the memory CD8+ T cell responses in the spleen.
We observed a higher frequency of KdM282–90 tetramer positive
cells than DbM187–195 tetramer positive cells in the spleens of
hybrid mice, indicating that the dominance in the magnitude of
response to this epitope was maintained (Fig. 4A). Only a
fraction of the RSV-specific CD8+ T cells to either epitope
produced cytokines upon in vitro peptide stimulation. Again,
TNF-α-producing cells were a subset of IFN-γ-producing CD8+
T cells. These results indicate that the KdM282–90 epitope
maintains dominance in the memory population. As an
additional measure of functionality, we measured the geometricmean fluorescence intensity (MFI) of IFN-γ production by CD8+
T cells following stimulation with M282–90 and M187–195
peptides (Fig. 4B). During primary infection, when a higher
proportion of DbM187–195-specific cells produce IFN-γ follow-
ing stimulation, more IFN-γ per cell is also produced as
measured by MFI. However, during the memory phase, the
KdM282–90-specific cells dominate quantitatively, as measured
by tetramer staining, and also produce more IFN-γ per cell than
DbM187–195-specific cells (Figs. 4A and B).
Discussion
We have described the CD8+ T cell response to two
dominant epitopes, KdM282–90 and D
bM187–195 (Kulkarni et al.,
1993; Rutigliano et al., 2005), in RSV-infected H-2d/b hybrid
CB6F1/J mice where the consequences of epitope competition
on the T cell response can be independently studied. These
mice have been used previously to study the hybrid resistance
effect in LCMV infection (Doherty and Allan, 1986a, 1986b).
We suggest that the hybrid mouse model provides a system to
define the rules of epitope hierarchy and to better understand
the determinants of CD8+ T cell effector functions. The system
allows for adoptive transfer of cells from either parent strain
into the hybrid mouse to define the role of antigen presentation
or CD4+ T cell help in determining the functional character-
Fig. 4. Memory CD8+ T cell responses to RSV infection in CB6F1/J mice. (A)
KdM282–90- and D
bM187–195-specific CD8+ T cells were measured by tetramer
staining of CB6F1/J spleen lymphocytes 42 days after RSV infection. Antiviral
cytokine production by memory CD3+CD8+ T cells was determined separately
by ICS after stimulation with epitope-specific peptide and co-stimulation with
anti-CD49d and anti-CD28. Averages and standard deviations were calculated
from results for 5 mice per group, and the data are representative of 3
independent experiments. P<0.05 between KdM82–90 and D
bM187–195 epitopes
for both tetramer and cytokine responses, Student's t-test. (B) Geometric mean
fluorescence intensity (MFI) of IFN-γ production by CD8+ T cells following
M282–90 and M187–195 peptide stimulation of lung (days 6–10) and spleen
(memory) lymphocytes.
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system to address whether patterns of epitope hierarchy can be
modified by vaccination or the conditions under which antigen
presentation occurs. In addition, sorting and clonotyping
epitope-specific T cells following vaccination or RSV infection
will augment our understanding of how clonal selection
and TCR clonotype patterns influence CD8+ T cell pheno-
types. These questions are under active investigation in our
laboratory.
Despite exhibiting dominance in parent C57Bl/6 mice, the
DbM187–195 epitope became subdominant to the K
dM282–90
epitope in H-2d/b mice. It has previously been shown that there
is no haplotype preference in H-2d/b mice (Thomsen and
Marker, 1989). However, another study that looked at CB6F1/J
chimeras infected with Listeria monocytogenes strain EJL243,
which co-expresses the secreted LCMV NP protein, also
showed that the H2-Kd-restricted response was dominant
compared to the H2-Db-restricted response (Lenz et al.,
2000). Evaluation of relative MHC class I expression in F1
hybrid mice suggested that H-2b and H-2d MHC class Imolecules are similarly expressed on the cell surface in H-2b/d
mice, although the mixing of alleles in other F1 hybrids may
result in unequal expression (Tourdot and Gould, 2002), and
epitope-specific effects may occur. Studies from Harty et al.
have shown that CD8+ T cell contraction may be prepro-
grammed and controlled by early inflammation (Badovinac et
al., 2002, 2004). Similarly, it has recently been proposed by
Doherty's group that clonal expansion of CD8+ T cells in
response to certain influenza epitopes may ensue from a preset
pattern (Thomas et al., 2006). Our studies, combined with the
recent description of minor Db-restricted epitopes (Lukens et
al., 2006), may provide a system to help define the principles
underlying CD8+ Tcell response patterns after RSV infection or
immunization.
Interestingly, we found that although the DbM187–195
response was quantitatively subdominant in CB6F1/J hybrid
mice, almost all M187–195-specific cells produce IFN-γ after
peptide stimulation. In contrast, only a fraction of KdM282–90-
specific cells produce IFN-γ after stimulation. During primary
infection, DbM187–195-specific cells also produce more IFN-γ
per cell than KdM282–90-specific as measured by MFI. These
differences are not maintained in the memory phase, where
the M2 response is both quantitatively and functionally
dominant. These data suggest that the more functionally
active DbM187–195-specific cells may have the capacity for
effector function during primary infection, but less often survive
into the memory phase. Using the hybrid mouse model to
further define ancillary responses and host factors involved in
establishing epitope hierarchy, and the function of epitope-
specific cells, will help establish the contribution of subdomi-
nant T cell epitopes in viral pathogenesis and potentially inform
T cell-based vaccine design.
Materials and methods
Mice
Pathogen-free BALB/c, C57Bl/6, and CB6F1/J female mice
between the ages of 6 and 10 weeks were purchased from
Charles River Laboratories (Raleigh, NC) or Jackson Labora-
tories (Bar Harbor, ME). CB6F1/J mice are the F1 generation of
a C57Bl/6×BALB/c mating, and therefore express both H-2b
and H-2d class I MHC proteins. All animal work was approved
by the NIH Animal Care and Use Committee. The mice were
cared for in accordance with the Guide for the Care and Use of
Laboratory Animals, as described previously (Graham et al.,
1988). Experiments were performed with age-matched groups.
Cell lines and antibodies
HEp-2 cells were used to titer RSV from lungs. Cells were
maintained in Eagle's minimal essential media containing 10%
fetal bovine serum (10% EMEM), and were supplemented with
2 mM glutamine, 10 U of penicillin G per ml, and 10 μg of
streptomycin sulfate per ml. Cells were determined to be free of
mycoplasma contamination by analysis with the polymerase
chain reaction (ATCC, Manassas, VA).
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The RSV challenge stock was derived from the A2 strain of
RSV by sonication of HEp-2 monolayers as previously
described (Graham et al., 1988). Mice were anesthetized
intramuscularly with ketamine (40 μg/g body weight) and
xylazine (6 μg/g body weight) prior to intranasal inoculation
with 107 pfu live RSV in 100 μl of 10% EMEM. Mice were
weighed daily after infection, and percent weight lost was used
to assess the severity of illness.
Plaque assays
Mice were sacrificed and lung tissue was removed and
quick-frozen in 10% EMEM. Thawed tissues were kept chilled
while individually ground. Dilutions of clarified supernatant
were inoculated on 80% confluent HEp-2 cell monolayers in
triplicate and overlaid with 0.75% methyl cellulose in 10%
EMEM. After incubation for 4 days at 37 °C, the monolayers
were fixed with 10% buffered formalin and stained with
hematoxylin and eosin. Plaques were counted and expressed as
log10 pfu/g of tissue. The limit of detection is 1.8 log10 pfu/g of
tissue in this assay.
Synthetic peptides
RSV M282–90 (SYIGSINNI) and RSV M187–195
(NAITNAKII) were derived from the M2 and M proteins,
respectively, of the RSV-A2 strain (Kulkarni et al., 1993;
Rutigliano et al., 2005). M2 82–90 is H2-Kd-restricted and
M187–195 is H2-D
b-restricted. Negative control peptides were
derived from the influenza virus A/Puerto Rico/8/34 nucleo-
protein (NP) 147–155 (TYQRTRALV), which is H2-Kd-
restricted. Influenza virus NP366–374 (ASNENMETM) is
derived from influenza virus A/Puerto Rico/8/34 and is H2-
Db-restricted. Peptides were synthesized by Anaspec, Inc.
(San Jose, CA), and confirmed to be >95% pure by analytical
high-performance liquid chromatography at the NIAID
peptide core facility (Bethesda, MD).
Tetramers
Class I MHC tetramers were synthesized by Beckman
Coulter (San Diego, CA). Virus-specific T cells were enumer-
ated with PE-labeled tetrameric complexes of H2-Kd plus the
RSV M282–90 peptide or APC-labeled tetrameric complexes of
H2-Db plus the RSV M187–195 peptide. For negative controls,
PE-labeled tetrameric complexes of H2-Db plus the influenza
NP366–374 peptide or H2-K
d plus the influenza NP147–155
peptide were used.
Tetramer and intracellular cytokine staining (ICS)
Mice were sacrificed and lungs harvested at various times
between days 4 and 14 post-infection. Spleens were also
harvested between 4 and 8 weeks post-infection to analyze
memory responses. Lymphocytes were isolated manually bygrinding organ tissue between the frosted ends of two sterile
glass microscope slides in RPMI containing 10% FBS (10%
RPMI). Lymphocytes were isolated by centrifugation on a
cushion of Ficoll/Hypaque at room temperature, washed, and
resuspended in 10% RPMI. Lymphocytes were incubated at
37 °C for 5–6 hours with 1 μg of the appropriate peptide and
1 μg/ml of the co-stimulatory antibodies against CD28 and
CD49d. After 1 h of incubation, 1 μg/ml of monensin was
added to retain newly synthesized proteins within the cell. As a
positive control, cells were stimulated with 10 ng/ml PMA and
1 μM ionomycin. After the incubation, cells were fixed and
permeabilized according to the manufacturer's instructions
(BD Pharmingen, San Diego, CA) and stained with
fluorochrome-conjugated antibodies against CD3, CD8, IFN-
γ, and TNF-α (BD Pharmingen) for 20 min at 4 °C. In some
experiments, cells were stained with a fluorochrome-con-
jugated antibody against CD49b to identify natural killer
(NK) cells. For tetramer analysis, cells were stained with
KdM282–90 tetramer and D
bM187–195 in addition to antibodies
against CD3 and CD8. Tetramers that recognized the
influenza NP366–374 was used as a negative control. After
staining, cells were washed and analyzed by flow cytometry.
Cells were analyzed on a FACSCaliber (Becton Dickinson, San
Jose, CA) argon-ion laser at 15 mW and 488 nm. Data were
analyzed by using FlowJo version 6.3 (Tree Star, San Carlos,
CA).
Statistical analysis
Two-tailed Student's t test was used for comparison of
means, and values of P<0.05 were considered statistically
significant.
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